MAZE — MAZE THERAPEUTICS INC

Ownership history in Caption Management, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in MAZE THERAPEUTICS INC (MAZE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q3)
Avg. % of fund
0.0%
First filed
2025 Q3
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 4,000 -26,000 -86.7% 0.00% $104K $25.93
2025 Q3 INITIATED 30,000 — — 0.01% $778K $25.93
% of Fund (quarterly)    MAZE price (monthly, adj. close)

Other funds also holding MAZE

As of 2025 Q4 — sorted by position size

TRV GP IV, LLC 3Y 72.65% Matrix Capital Management Company, LP 3Y 7Y 34.52% ARCH Venture Management, LLC 3Y 7Y 26.19% General Catalyst Group Management, LLC 3Y 7Y 19.35% Foresite Capital Management IV, LLC 3Y 7Y 9.43% TRV GP V, LLC 9.18% WASHINGTON UNIVERSITY 3Y 5.88% Frazier Life Sciences Management, L.P. 3Y 5.08% a16z Capital Management, L.L.C. 4.46% VR Adviser, LLC 3Y 3.17%
← Back to Caption Management, LLC Holdings